Semaglutide NAION Risk: EMA Review Initiated Am...

By João L. Carapinha

January 21, 2025

The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) is reviewing the potent...
Cost-Effective Cervical Cancer Screening Strategies for Women with HIV in Kwa...
Cost-Effectiveness of Switching to the Nonavalent HPV Vaccine in the Netherlands
GLP-1 Receptor Agonists: Balancing Benefits and Risks in Treatment Decisions
Valuable, Cost-Effective Thyroid Cancer Diagnosis
WHO Prequalifies First G6PD Diagnostic Test
Advancing Newborn Screening for Sickle Cell Disease in Africa
Diabetes Drugs Safe from Thyroid Cancer Risk, Study Finds
Thyroid Eye Disease Therapy: Insights from Viridian Therapeutics’ THRIV...
Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prev...
Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak
BioSapien Innovative Cancer Drug Delivery Solutions
Lenacapavir Injection: A Breakthrough in Global HIV Prevention